Abiopharma

New Form 144 - Aquestive Therapeutics, Inc. Filed: 2025-09-04 AccNo: 0001950047-25-006754 Size: 6 KB

New Form 8-K - Safety Shot, Inc. Filed: 2025-09-04 AccNo: 0001641172-25-026592 Size: 255 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

UTHR: Notification

New Form 144 - VERACYTE, INC. Filed: 2025-09-04 AccNo: 0001950047-25-006751 Size: 4 KB

New Form DEFA14A - Catheter Precision, Inc. Filed: 2025-09-04 AccNo: 0001437749-25-028375 Size: 17 KB

New Form 144 - Arcutis Biotherapeutics, Inc. Filed: 2025-09-04 AccNo: 0002007317-25-001027 Size: 9 KB

New Form S-3/A - Tonix Pharmaceuticals Holding Corp. Filed: 2025-09-04 AccNo: 0001999371-25-012583 Size: 108 KB

New Form 144 - UNITED THERAPEUTICS Corp Filed: 2025-09-04 AccNo: 0001950047-25-006741 Size: 8 KB

Burkly Linda 🔴 sold 710 shares of Editas Medicine, Inc. (EDIT) at $2.60 Transaction Date: Sep 03, 2025 | Filing ID: 000143

NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients

Parison Amy 🔴 sold 458 shares of Editas Medicine, Inc. (EDIT) at $2.60 Transaction Date: Sep 03, 2025 | Filing ID: 000142

New Form 8-K - Aptevo Therapeutics Inc. Filed: 2025-09-04 AccNo: 0001671584-25-000005 Size: 203 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 144 - NEKTAR THERAPEUTICS Filed: 2025-09-04 AccNo: 0001959173-25-005776 Size: 7 KB

New Form 144 - Butterfly Network, Inc. Filed: 2025-09-04 AccNo: 0001959173-25-005775 Size: 4 KB

Plataforma Designed Enzymatic Biomaterials™ projetada pela IFF é usada pela primeira vez em grande escala em aplicações de cuidados domiciliares